You are here

News and Events

For an overview of the latest news, press releases and blog posts from Cancer Research UK visit the Cancer News page.

Below you will find the latest press releases, news and event information from the Cancer Research UK Commercial Partnerships team and our legal entity, Cancer Research Technology (CRT).

Date1	Press Release
16 December 2014	CRT Pioneer Fund banks £20m investment from BACIT and expands agreement with Chroma Therapeutics to develop cancer immunotherapies	Read more
10 December 2014	Three new companies join Cancer Research UK-Abcodia collaboration to identify blood markers for early cancer detection	Read more
28 November 2014	Cancer Research UK to collaborate with AstraZeneca in screening for new cancer medicines at the AstraZeneca MRC UK Centre for Lead Discovery	Read more
26 November 2014	BACIT seeks shareholder approval to commit £20m and join CRT Pioneer Fund as a limited partner	Read more
21 November 2014	£50M CRT Pioneer Fund announces investment to develop lung cancer drugs at Cancer Research UK's Manchester Institute	Read more
27 October 2014	Cancer Research UK and Leukaemia & Lymphoma Research team up to boost blood cancer trials	Read more
20 October 2014	Cancer Research Technology introduces Ximbio, an online reagents portal	Read more
25 September 2014	Cancer Research UK and MedImmune establish joint CRUK-MEDI Alliance Laboratory to develop new biologic cancer medicines	Read more
23 September 2014	Inivata raises £4m to realise the potential of ctDNA analysis to improve cancer treatment through simple blood tests	Read more
11 September 2014	Cancer Research UK, Cancer Research Technology and Asterias Biotherapeutics partner to trial immunotherapy vaccine for lung cancer	Read more

Pages

Date	Other news
30 January 2012	Curis Announces FDA Approval of Erivedge (vismodegib) Capsule as First Treatment for Advanced BCC
15 December 2011	Call for Reagents
15 December 2011	Stephen Friend visits CRT to discuss Arch2POCM
15 December 2011	FEATURE: Successful Discovery Committee grant application shows promise for novel drug combinations
15 December 2011	FEATURE: CRT reflects on a successful NCRI conference
15 December 2011	FEATURE: CCR4 - from target discovery to a license and sponsored collaboration with Affitech
1 September 2011	CRT's Discovery Laboratory Autotaxin programme progresses to Lead Optimisation
19 August 2011	Preclinical Development Candidate selected for Chk1 Inhibitor Programme
28 July 2011	FEATURE: Abiraterone receives approval from FDA to be marketed as a prostate cancer therapy - Zytiga
28 July 2011	FEATURE: BliNK Therapeutics, our 24th spin-out company is formed

Pages